{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Oseltamivir Phosphate is a generic antiviral medication used to treat and prevent influenza (flu) in adults and children. It works by inhibiting the neuraminidase enzyme, helping to stop the virus from spreading. Available as oral capsules in strengths of 30mg, 45mg, and 75mg, it's prescribed by a doctor. Manufactured by Lupin Pharmaceuticals, Inc. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Oseltamivir phosphate \u2014 ANDA 217467 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217467", "mediaType": "text/html", "title": "Oseltamivir phosphate"}], "identifier": "ANDA217467", "issued": "2016-09-16", "keyword": ["health-care", "drug-safety", "fda", "public-health", "drug-manufacturers"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Oseltamivir phosphate"}